MabVax Therapeutics And Telik Sign Definitive Merger Agreement

[PR Newswire] – SAN DIEGO, May 12, 2014 /PRNewswire/ — MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (TELK), aclinical stage oncology drug development company have entered into a definitive merger agreement. Up more

View todays social media effects on TELK

View the latest stocks trending across Twitter. Click to view dashboard

See who Telik is hiring next, click here to view